Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Health Serv Res
Prif Awduron: Shimizu, Reiko, Ogata, Katsuhisa, Tamaura, Akemi, Kimura, En, Ohata, Maki, Takeshita, Eri, Nakamura, Harumasa, Takeda, Shin’ichi, Komaki, Hirofumi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Technical Advance
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939632/
https://ncbi.nlm.nih.gov/pubmed/27401940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-016-1477-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg